PharmaBoardroom

Yelda Ulu Colin – General Manager, GE Healthcare Turkey

Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city hospitals project, highlighting the…

Turkish Pharma: Eyeing Up Exports

Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing, Turkish companies are looking to…

Stephen Matlin – CEO, Life Length, Spain

Stephen Matlin, CEO of Life Length, highlights the evolution of the company over recent years, especially the establishment of their own laboratories…

China Set to Become OxyContin’s Second Largest Market

China is set to become the second largest market for Mundipharma’s OxyContin behind the US. It comes as no surprise that sales of…

Spain: Big Ticket Infrastructural Investments

Against an alluring backdrop, big-name pharma brands are now starting to spend heavily on in-country manufacturing, development and shared service…

Hakhyun Nam – Co-Founder & Chief Technology Officer,…

Hakhyun Nam, co-founder and CTO at i-SENS, Inc. a developer of glucose sensor devices, reveals his path to running a globally successful medical…

Dan Zhang – Executive Chairman, Fountain Medical…

Dr Dan Zhang, CEO of Fountain Medical Development (FMD), details the transformation China’s recent membership at the International Conference on…

Philippe Truelle – President, CDM Lavoisier, France

Philippe Truelle, President of CDM Lavoisier, highlights the financial impact of the EU’s Falsified Medicines Directive (FMD) on SMEs across Europe…

Ramón Villamarín Valdenebro – General Manager, Shionogi…

Ramón Villamarín Valdenebro, general manager of Shionogi Spain, highlights the key steps that needed to be taken to establish the affiliate over the…

Julien Samson – Vice President and General Manager, GSK…

Julien Samson, vice president and general manager of GSK Korea explains how GSK’s new global strategy is being delivered within the Korean…

Wang Yinxiang – Chairman & Hu Shaojing – President,…

Dr Wang Yinxiang, chairman; and Dr Hu Shaojing, President (R&D); of Jacobio Pharmaceutical; share the exciting story behind Jacobio’s…

Frédéric Collet – President Novartis France and General…

Frédéric Collet, president Novartis France and general manager oncology explains the rationale behind Novartis’s consistent investment in…

Tagged with